Trial Profile
Phase IIa trial of a fixed-dose combination of leucine, metformin and a PDE5 inhibitor
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 09 Jun 2015
Price :
$35
*
At a glance
- Drugs Leucine/metformin/sildenafil (Primary)
- Indications Non-alcoholic fatty liver disease
- Focus Therapeutic Use
- Sponsors NuSirt Biopharma
- 09 Jun 2015 New trial record
- 06 Jun 2015 Initiation of this trial is planned later in 2015, according to a NuSirt Biopharma media release.